Send Inquiry

Request To Call Back

Bryxta 400

Name: Bryxta 400
Brand: Ezan Pharmaceuticals
Price: 10000 INR
Availability: InStock

Price 10000 INR/ Unit

Get a Price/Quote

MOQ : 1 Pack

Bryxta 400 Specification

Life Span
24 months from date of manufacture

Brand Name
Bevatas

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Metastatic colorectal cancer, Glioblastoma, Cervical cancer, Ovarian cancer, Renal cell carcinoma

Packaging Type
Vial

Dosage Form
Injection

Salt Composition
Bevacizumab

Origin of Medicine
India

Drug Type
Other

Ingredients
Bevacizumab

Physical Form
Other

Function
Other

Recommended For
Anti-cancer therapy

Dosage
As prescribed by physician

Dosage Guidelines
Use under medical supervision only

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Use in Pregnancy
Not recommended

Contraindications
Hypersensitivity to Bevacizumab or any excipients

Use in Lactation
Not recommended

Strength
100 mg/4 ml or 400 mg/16 ml

Storage Condition
Store below 8C, do not freeze, keep away from light

Prescription Required
Yes

Disposal
Unused medicine must be disposed of in accordance with local requirements

Side Effects
Hypertension, bleeding, proteinuria, thromboembolism

Administration Route
Intravenous infusion only

Appearance
Clear, colorless to pale yellow solution

ATC Code
L01XC07

Shelf Life
2 years from date of manufacture

Bryxta 400 Trade Information

Minimum Order Quantity
1 Pack

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
1 Days

Main Domestic Market
All India, Arunachal Pradesh, Tripura, Meghalaya, Mizoram, Nagaland, Manipur, Assam

About Bryxta 400

Bevatas Bevacizumab Injection is a first-class, affordable monoclonal antibody designed for distinguished anti-cancer therapy. Available in strengths of 100 mg/4 ml or 400 mg/16 ml, this special formula is presented as a clear, colorless to pale yellow solution for intravenous infusion only. Prescription is mandatory for purchase. Manufactured in India, each vial offers sterling efficacy against metastatic colorectal cancer, glioblastoma, cervical, ovarian, and renal cell carcinomas. Bevatas' shelf life extends up to 2 years. Experience this exceptional pharmaceutical solution at a special sale price, ensuring both quality and value for patients and healthcare providers.

Applications and Mode of Use

Bevacizumab Injection is widely applied in oncology treatment, specifically used as a monoclonal antibody for various advanced cancers. This solution is utilized strictly through intravenous infusion under medical supervision, exemplifying its first-class efficacy in anti-cancer therapy. Suitable for adult patients only, the medication is provided in liquid injection form and is essential for treating metastatic colorectal cancer and other malignancies. Medical institutions and hospitals often employ this product due to its established benefits and application value.

Swift Delivery and Reliable Supply

Our export market reach ensures Bevatas Bevacizumab Injection is shipped promptly upon request with secure packaging. Each order-one vial per box-is carefully handled and handed over to clients across the main domestic markets of India and abroad. Supply ability remains robust, catering to urgent clinical needs with dependable timelines. As a distinguished trader and supplier, we excel in timely deliveries to healthcare providers and practitioners, upholding strict standards for quality and reliability.

FAQ's of Bevacizumab Injection:

Q: How is Bevacizumab Injection administered to patients?

A: Bevacizumab Injection must be administered via intravenous infusion only, under the supervision of a qualified healthcare professional. The dosage and infusion rate should be determined as prescribed by the treating physician.

Q: What are the main medical indications for using Bevacizumab Injection?

A: This medication is primarily indicated for the treatment of various cancers, including metastatic colorectal cancer, glioblastoma, cervical cancer, ovarian cancer, and renal cell carcinoma.

Q: When should Bevacizumab Injection not be used?

A: The injection should not be used in patients with known hypersensitivity to Bevacizumab or any of its excipients. Its use is also not recommended during pregnancy and lactation.

Q: Where should Bevacizumab Injection be stored to ensure efficacy?

A: To maintain stability and efficacy, the vial must be stored in a refrigerator at temperatures between 2C and 8C, protected from direct light, and never frozen.

Q: What are the potential side effects associated with Bevacizumab Injection?

A: Possible side effects include hypertension, bleeding, proteinuria, and thromboembolism. All patients should be monitored for these reactions during treatment.

Q: How is the unused or expired Bevacizumab Injection disposed of?

A: Any unused or expired medication must be disposed of according to local medical waste regulations to ensure safety and compliance with environmental standards.

Tell us about your requirement